Purified lymphocyte function‐associated antigen‐3 and T11 target structure are active in CD2‐mediated T cell stimulation
- 1 January 1987
- journal article
- research article
- Published by Wiley in European Journal of Immunology
- Vol. 17 (12) , 1847-1850
- https://doi.org/10.1002/eji.1830171227
Abstract
In this study we have used cells expressing LFA-3 or T11TS, the human and sheep forms of the ligand of CD2, as well as the purified LFA-3 and T11TS molecules themselves to study their effects on T cell activation via the CD2-mediated “alternative pathway”. Sheep red blood cells, which bind to CD2 via T11TS in E-rosette formation, and human autologous monocytes, which express the LFA-3 molecule, both induce proliferation of resting T cells in the presence of per se submitogenic concentrations of anti-T112 plus anti-T113 monoclonal antibodies (mAb). This effect is blocked by mAb to LFA-3, T11TS and CD2 known to inhibit CD2-ligand interaction. In addition, purified LFA-3 and T11TS, when added at ng amounts to cultures containing submitogenic concentrations of anti-T112 + 3 mAb, are also strongly mitogenic for resting human T cells. Thus, both LFA-3 and T11TS are potent co-stimulators of the alternative pathway of T cell activation but by themselves do not provide a mitogenic signal. This finding is discussed with regard to a physiological role of CD2-LFA-3 interaction in T cell activation.This publication has 19 references indexed in Scilit:
- The T lymphocyte glycoprotein CD2 binds the cell surface ligand LFA-3Nature, 1987
- Alternative pathway activation of T cells by binding of CD2 to its cell-surface ligandNature, 1987
- Purified lymphocyte function-associated antigen 3 binds to CD2 and mediates T lymphocyte adhesion.The Journal of Experimental Medicine, 1987
- Rosetting of activated human T lymphocytes with autologous erythrocytes. Definition of the receptor and ligand molecules as CD2 and lymphocyte function-associated antigen 3 (LFA-3).The Journal of Experimental Medicine, 1987
- Two antigen-independent adhesion pathways used by human cytotoxic T-cell clonesNature, 1986
- T cell stimulation via the erythrocyte receptor. Synergism between monoclonal antibodies and phorbol myristate acetate without changes of free cytoplasmic Ca++ levels.The Journal of Experimental Medicine, 1986
- Anti‐CD2 (sheep red blood cell receptor) monoclonal antibodies and T cell activation I. Pairs of anti‐T11.1 and T11.2 (CD2 subgroups) are strongly mitogenic for T cells in presence of 12‐O‐tetradecanoylphorbol 13‐acetateEuropean Journal of Immunology, 1986
- The cell surface molecule recognized by the erythrocyte receptor of T lymphocytes. Identification and partial characterization using a monoclonal antibody.The Journal of Experimental Medicine, 1985
- An alternative pathway of T-cell activation: A functional role for the 50 kd T11 sheep erythrocyte receptor proteinCell, 1984
- A rapid method for the isolation of functional thymus‐derived murine lymphocytesEuropean Journal of Immunology, 1973